Logo image
IRO Home Research units Researcher Profiles
Sign in
p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer
Journal article   Peer reviewed

p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer

Debra G B Leonard, Lois B Travis, Kathakali Addya, Graca M Dores, Eric J Holowaty, Kjell Bergfeldt, David Malkin, Betsy A Kohler, Charles F Lynch, Tom Wiklund, …
Clinical cancer research, Vol.8(5), pp.973-985
05/2002
PMID: 12006509

View Online

Abstract

Humans Middle Aged Combined Modality Therapy Ovarian Neoplasms - complications Ovarian Neoplasms - radiotherapy Myelodysplastic Syndromes - complications DNA, Neoplasm - chemistry Tumor Suppressor Protein p53 - genetics Cisplatin - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use DNA Mutational Analysis Leukemia - complications Base Sequence Adult Female Aged Myelodysplastic Syndromes - genetics DNA, Neoplasm - genetics Mutation Ovarian Neoplasms - drug therapy Leukemia - genetics

Details

Metrics

Logo image